Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study
    Journal Article

    Langballe, R.; Mellemkjær, L.; Malone, K. E.; Lynch, C. F.; John, E. M.; Knight, J. A.; Bernstein, L.; Brooks, J.; Andersson, M.; Reiner, A. S.; more...
    Breast Cancer Research (2016)

    Fulltext@MSK | Save
  • Management of non-BRCA breast cancer predisposition
    Meeting Abstract

    Robson, M.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Information preferences and short-term psychological responses to multiplex genetic testing among individuals at risk for hereditary breast cancer
    Meeting Abstract

    Robson, M. E.; Gaissert, P.; Salo-Mullen, E. E.; Amoroso, K.; Sheehan, M.; Berliner, J. L.; Trottier, M.; Arnold, A. G.; Sekhri, N.; Marcell, V.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • ABRAZO: An international phase 2 (2-stage, 2-cohort) study of the oral PARP inhibitor talazoparib (BMN 673) in BRCA mutation subjects with locally advanced and/or metastatic breast cancer
    Meeting Abstract

    Turner, N. C.; Balmana, J.; Fasching, P. A.; Hurvitz, S. A.; Rugo, H. S.; Telli, M. L.; Visco, F.; Wardley, A. M.; Yang, X.; Lokker, N. A.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • All-cause survival estimates compared to observed survival in older women with breast cancer in CALGB 49907 and 369901 (Alliance A151503)
    Meeting Abstract

    Kimmick, G.; Pitcher, B.; Mandelblatt, J.; Clapp, J.; Balman, K.; Barginear, M.; Freedman, R.; Artz, A.; Klepin, H.; Lafky, J.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Survival benefit needed to undergo chemotherapy: Patients and physicians preferences
    Meeting Abstract

    Luis, I. V.; O'Neill, A.; Sepucha, K.; Miller, K. D.; Baker, E.; Dang, C. T.; Northfelt, D. W.; Winer, E. P.; Sledge, G. W.; Schneider, B. P.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Phase 1b/2 study of intratumoral Ad-RTS-hIL-12 + veledimex in patients with chemotherapy-responsive locally advanced or metastatic breast cancer
    Meeting Abstract

    McArthur, H. L.; Page, D.; Proverbs-Singh, T.; Solomon, S.; Hudis, C.; Norton, L.; Patil, S.; Barrett, J. A.; Lebel, F.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Capturing intra-tumor genetic heterogeneity in cell-free plasma DNA from patients with oligometastatic breast cancer
    Meeting Abstract

    Ng, C. K. Y.; Bidard, F. C.; Piscuoglio, S.; Lim, R. S.; Pierga, J. Y.; Cottu, P.; Vincent-Salomon, A.; Viale, A.; Norton, L.; Sigal, B.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • cfDNA analysis from BOLERO-2 plasma samples identifies a high rate of ESR1 mutations: Exploratory analysis for prognostic and predictive correlation of mutations reveals different efficacy outcomes of endocrine therapy-based regimens
    Meeting Abstract

    Chandarlapaty, S.; Sung, P.; Chen, D.; He, W.; Samoila, A.; You, D.; Bhatt, T.; Patel, P.; Voi, M.; Gnant, M.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • MDV3100-08: A phase 1 study evaluating the safety and pharmacokinetics of enzalutamide plus fulvestrant in women with advanced hormone receptor-positive breast cancer
    Meeting Abstract

    Elias, A. D.; Burris, H. A.; Patel, M. R.; Schwartzberg, L. S.; Richer, J. K.; Kavalerchik, E.; Stopatschinskaja, S.; Gibbons, J.; Markova, D.; Steinberg, J. L.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save